Business Context and Reporting Period
Company: Nano Labs Ltd
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: June 2025 (Current report furnished June 25, 2025)
Headquarters: Hangzhou, Zhejiang, People's Republic of China
This filing incorporates by reference three exhibits: a press release (Exhibit 99.1), a Convertible Note Purchase Agreement (Exhibit 99.2), and the Form of Convertible Note (Exhibit 99.3). These documents are part of the Registration Statement on Form F-3 filed on August 14, 2023.
Key Financial Metrics
The filing text provided does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a procedural report to incorporate external exhibits rather than a standalone financial statement.
Material Changes
The primary material event disclosed is the execution of a convertible note financing arrangement, evidenced by the inclusion of the purchase agreement and note form. No comparative financial performance data is provided in the text to assess changes versus prior periods.
Guidance, Outlook, and Risks
Management Commentary: The filing notes that descriptions in the press release are qualified in their entirety by reference to the complete text of the convertible note purchase agreement and the convertible note itself.
Risks and Contingencies: The filing does not explicitly list new risks or contingencies in the main text, deferring to the incorporated exhibits for full details on the terms of the convertible notes.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the specific terms and amount of the convertible note financing.
- Analyze Exhibit 99.2 and 99.3 to understand conversion rates, interest terms, maturity dates, and covenants of the new debt.
- Verify the impact of this financing on the company's existing capital structure and potential dilution.
- Confirm the status of the Form F-3 Registration Statement (No. 333-273968) referenced in the explanatory note.